Blake Lee Neubauer

About Blake Lee Neubauer

Teichos Laboratories, LLC.(Teichos) is a business-to-business biotechnology company that employs chemoenzymatic synthesis to access its platform of macromolecular biologics for diverse applications in immunotherapy and vaccine development. Collectively, Teichos members possess deep experience in human and veterinary drug development with start-up and large pharmaceutical organizations. Teichos partners with academic collaborators to generate proof-of-concept data for specific disease applications with the goal to establish developmental agreements with immunotherapy-focused partners for commercialization. Our products offer disruptive innovation in immunotherapy with broad applications in human and animal disease prevention and treatment.

Experience

1. Co-founder & Member- Biological Sciences

   Teichos Laboratories, Llc

   Nov 2017 — Present · Central, IN, US

Education

• UC Irvine

  B.S., Biological Sciences

  1971 — 1975

• University of Colorado

  Post-Doctoral Fellowship, Developmental Biology and Biochemical Pharmacology

  1979 — 1981

• West Virginia University

  Ph.D., Pharmacology and Toxicology

  1975 — 1979

Skills

• Immunology
• Biopharmaceuticals
• Chromatography
• Toxicology
• Clinical Development
• Clinical Research
• Adme
• Pharmacology
• Regulatory Affairs
• Assay Development
• Biomarkers
• Vaccines
• Technology Transfer
• Molecular Biology
• Cell
• Protein Chemistry
• Lifesciences
• Biotechnology
• Drug Metabolism
• Analytical Chemistry
• Regulatory Submissions
• Ind
• Cell Biology
• Elisa
• In Vitro
• Hplc
• Research
• Cell Culture
• Cancer
• Drug Discovery
• Neuroscience
• Translational Medicine
• CRO
• Oncology
• Gmp
• Drug Development
• Pharmaceutical Industry
• Pharmacokinetics
• Validation
• Clinical Trials